img

Global Over-the-Counter Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Over-the-Counter Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Over-the-Counter Drugs market size was US$ 42040 million in 2022 and is forecast to a readjusted size of US$ 48990 million by 2034 with a CAGR of 1.8% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Analgesics & Pain Relievers accounting for % of the Over-the-Counter Drugs global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The global key companies of Over-the-Counter Drugs include Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, GlaxoSmithKline and Boehringer Ingelheim, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Over-the-Counter Drugs market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Over-the-Counter Drugs landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Over-the-Counter Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Over-the-Counter Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Over-the-Counter Drugs market. Readers of the report can become informed about current and future trends of the global Over-the-Counter Drugs market and how they will impact market growth during the forecast period.



By Company


Johnson & Johnson
Merck
Novartis
Pfizer
Sanofi
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
GlaxoSmithKline
Boehringer Ingelheim
Bayer
Alkem Laboratories
Glenmark Pharmaceuticals
Cipla
Segment by Type
Analgesics & Pain Relievers
Cough, Cold and Flu Products
Dermatological Products
Vitamin & Mineral Supplements
Gastrointestinal Products
Sleep Aids
Weight Loss Products
Smoking Cession Aids
Ophthalmic Products
Other

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Over-the-Counter Drugs in global and regional level.
Chapter 3Detailed analysis of Over-the-Counter Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over-the-Counter Drugs revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over-the-Counter Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Analgesics & Pain Relievers
1.2.3 Cough, Cold and Flu Products
1.2.4 Dermatological Products
1.2.5 Vitamin & Mineral Supplements
1.2.6 Gastrointestinal Products
1.2.7 Sleep Aids
1.2.8 Weight Loss Products
1.2.9 Smoking Cession Aids
1.2.10 Ophthalmic Products
1.2.11 Other
1.3 Market by Application
1.3.1 Global Over-the-Counter Drugs Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Over-the-Counter Drugs Market Size (2018-2034)
2.2 Over-the-Counter Drugs Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Over-the-Counter Drugs Market Size by Region (2018-2024)
2.4 Global Over-the-Counter Drugs Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Over-the-Counter Drugs Countries Ranking by Market Size
3 Over-the-Counter Drugs Competitive by Company
3.1 Global Over-the-Counter Drugs Revenue by Players
3.1.1 Global Over-the-Counter Drugs Revenue by Players (2018-2024)
3.1.2 Global Over-the-Counter Drugs Market Share by Players (2018-2024)
3.2 Global Over-the-Counter Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Over-the-Counter Drugs Revenue
3.4 Global Over-the-Counter Drugs Market Concentration Ratio
3.4.1 Global Over-the-Counter Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over-the-Counter Drugs Revenue in 2022
3.5 Global Key Players of Over-the-Counter Drugs Head office and Area Served
3.6 Global Key Players of Over-the-Counter Drugs, Product and Application
3.7 Global Key Players of Over-the-Counter Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Over-the-Counter Drugs Breakdown Data by Type
4.1 Global Over-the-Counter Drugs Historic Revenue by Type (2018-2024)
4.2 Global Over-the-Counter Drugs Forecasted Revenue by Type (2024-2034)
5 Global Over-the-Counter Drugs Breakdown Data by Application
5.1 Global Over-the-Counter Drugs Historic Market Size by Application (2018-2024)
5.2 Global Over-the-Counter Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Over-the-Counter Drugs Revenue by Company (2021-2024)
6.2 North America Over-the-Counter Drugs Revenue by Type (2018-2034)
6.3 North America Over-the-Counter Drugs Revenue by Application (2018-2034)
6.4 North America Over-the-Counter Drugs Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Over-the-Counter Drugs Revenue by Company (2021-2024)
7.2 Europe Over-the-Counter Drugs Revenue by Type (2018-2034)
7.3 Europe Over-the-Counter Drugs Revenue by Application (2018-2034)
7.4 Europe Over-the-Counter Drugs Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Over-the-Counter Drugs Revenue by Company (2021-2024)
8.2 Asia Pacific Over-the-Counter Drugs Revenue by Type (2018-2034)
8.3 Asia Pacific Over-the-Counter Drugs Revenue by Application (2018-2034)
8.4 Asia Pacific Over-the-Counter Drugs Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Over-the-Counter Drugs Revenue by Company (2021-2024)
9.2 Latin America Over-the-Counter Drugs Revenue by Type (2018-2034)
9.3 Latin America Over-the-Counter Drugs Revenue by Application (2018-2034)
9.4 Latin America Over-the-Counter Drugs Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Over-the-Counter Drugs Revenue by Company (2021-2024)
10.2 Middle East and Africa Over-the-Counter Drugs Revenue by Type (2018-2034)
10.3 Middle East and Africa Over-the-Counter Drugs Revenue by Application (2018-2034)
10.4 Middle East and Africa Over-the-Counter Drugs Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Over-the-Counter Drugs Products and Services
11.1.4 Johnson & Johnson Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.1.5 Johnson & Johnson Over-the-Counter Drugs SWOT Analysis
11.1.6 Johnson & Johnson Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Over-the-Counter Drugs Products and Services
11.2.4 Merck Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.2.5 Merck Over-the-Counter Drugs SWOT Analysis
11.2.6 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over-the-Counter Drugs Products and Services
11.3.4 Novartis Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.3.5 Novartis Over-the-Counter Drugs SWOT Analysis
11.3.6 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Over-the-Counter Drugs Products and Services
11.4.4 Pfizer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.4.5 Pfizer Over-the-Counter Drugs SWOT Analysis
11.4.6 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Over-the-Counter Drugs Products and Services
11.5.4 Sanofi Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.5.5 Sanofi Over-the-Counter Drugs SWOT Analysis
11.5.6 Sanofi Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Products and Services
11.6.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.6.5 Teva Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
11.6.6 Teva Pharmaceutical Industries Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Products and Services
11.7.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.7.5 Sun Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
11.7.6 Sun Pharmaceutical Industries Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Over-the-Counter Drugs Products and Services
11.8.4 GlaxoSmithKline Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.8.5 GlaxoSmithKline Over-the-Counter Drugs SWOT Analysis
11.8.6 GlaxoSmithKline Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Over-the-Counter Drugs Products and Services
11.9.4 Boehringer Ingelheim Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.9.5 Boehringer Ingelheim Over-the-Counter Drugs SWOT Analysis
11.9.6 Boehringer Ingelheim Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Over-the-Counter Drugs Products and Services
11.10.4 Bayer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.10.5 Bayer Over-the-Counter Drugs SWOT Analysis
11.10.6 Bayer Recent Development
11.11 Alkem Laboratories
11.11.1 Alkem Laboratories Company Details
11.11.2 Alkem Laboratories Business Overview
11.11.3 Alkem Laboratories Over-the-Counter Drugs Products and Services
11.11.4 Alkem Laboratories Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.11.5 Alkem Laboratories Recent Development
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Products and Services
11.12.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.12.5 Glenmark Pharmaceuticals Recent Development
11.13 Cipla
11.13.1 Cipla Company Details
11.13.2 Cipla Business Overview
11.13.3 Cipla Over-the-Counter Drugs Products and Services
11.13.4 Cipla Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024)
11.13.5 Cipla Recent Development
12 Over-the-Counter Drugs Market Dynamics
12.1 Over-the-Counter Drugs Industry Trends
12.2 Over-the-Counter Drugs Market Drivers
12.3 Over-the-Counter Drugs Market Challenges
12.4 Over-the-Counter Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Analgesics & Pain Relievers
Table 3. Key Players of Cough, Cold and Flu Products
Table 4. Key Players of Dermatological Products
Table 5. Key Players of Vitamin & Mineral Supplements
Table 6. Key Players of Gastrointestinal Products
Table 7. Key Players of Sleep Aids
Table 8. Key Players of Weight Loss Products
Table 9. Key Players of Smoking Cession Aids
Table 10. Key Players of Ophthalmic Products
Table 11. Key Players of Other
Table 12. Global Over-the-Counter Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 13. Global Over-the-Counter Drugs Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 14. Global Over-the-Counter Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 15. Global Over-the-Counter Drugs Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 16. Global Over-the-Counter Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 17. Global Over-the-Counter Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Over-the-Counter Drugs Market Share by Players (2018-2024)
Table 19. Global Top Over-the-Counter Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2022)
Table 20. Ranking of Global Top Over-the-Counter Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Over-the-Counter Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Over-the-Counter Drugs, Headquarters and Area Served
Table 23. Global Key Players of Over-the-Counter Drugs, Product and Application
Table 24. Global Key Players of Over-the-Counter Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Over-the-Counter Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Over-the-Counter Drugs Revenue Market Share by Type (2018-2024)
Table 28. Global Over-the-Counter Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Over-the-Counter Drugs Revenue Market Share by Type (2024-2034)
Table 30. Global Over-the-Counter Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Over-the-Counter Drugs Revenue Market Share by Application (2018-2024)
Table 32. Global Over-the-Counter Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Over-the-Counter Drugs Revenue Market Share by Application (2024-2034)
Table 34. North America Over-the-Counter Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 35. North America Over-the-Counter Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 36. North America Over-the-Counter Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 37. North America Over-the-Counter Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 38. North America Over-the-Counter Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 39. North America Over-the-Counter Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. North America Over-the-Counter Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 41. North America Over-the-Counter Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 42. Europe Over-the-Counter Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 43. Europe Over-the-Counter Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 44. Europe Over-the-Counter Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 45. Europe Over-the-Counter Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 46. Europe Over-the-Counter Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 47. Europe Over-the-Counter Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 48. Europe Over-the-Counter Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Europe Over-the-Counter Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Asia Pacific Over-the-Counter Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 51. Asia Pacific Over-the-Counter Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. Asia Pacific Over-the-Counter Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. Asia Pacific Over-the-Counter Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. Asia Pacific Over-the-Counter Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 55. Asia-Pacific Over-the-Counter Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Pacific Over-the-Counter Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 57. Asia Pacific Over-the-Counter Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 58. Latin America Over-the-Counter Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 59. Latin America Over-the-Counter Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 60. Latin America Over-the-Counter Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 61. Latin America Over-the-Counter Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 62. Latin America Over-the-Counter Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 63. Latin America Over-the-Counter Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Latin America Over-the-Counter Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 65. Latin America Over-the-Counter Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 66. Middle East and Africa Over-the-Counter Drugs Revenue by Company (2021-2024) & (US$ Million)
Table 67. Middle East and Africa Over-the-Counter Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Over-the-Counter Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 69. Middle East and Africa Over-the-Counter Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Over-the-Counter Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 71. Middle East and Africa Over-the-Counter Drugs Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 72. Middle East and Africa Over-the-Counter Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 73. Middle East and Africa Over-the-Counter Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Over-the-Counter Drugs Product and Services
Table 77. Johnson & Johnson Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 78. Johnson & Johnson Over-the-Counter Drugs SWOT Analysis
Table 79. Johnson & Johnson Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Over-the-Counter Drugs Product and Services
Table 83. Merck Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 84. Merck Over-the-Counter Drugs SWOT Analysis
Table 85. Merck Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Over-the-Counter Drugs Product and Services
Table 89. Novartis Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 90. Novartis Over-the-Counter Drugs SWOT Analysis
Table 91. Novartis Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Over-the-Counter Drugs Product and Services
Table 95. Pfizer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 96. Pfizer Over-the-Counter Drugs SWOT Analysis
Table 97. Pfizer Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Over-the-Counter Drugs Product and Services
Table 101. Sanofi Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 102. Sanofi Over-the-Counter Drugs SWOT Analysis
Table 103. Sanofi Recent Development
Table 104. Teva Pharmaceutical Industries Company Details
Table 105. Teva Pharmaceutical Industries Business Overview
Table 106. Teva Pharmaceutical Industries Over-the-Counter Drugs Product and Services
Table 107. Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 108. Teva Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
Table 109. Teva Pharmaceutical Industries Recent Development
Table 110. Sun Pharmaceutical Industries Company Details
Table 111. Sun Pharmaceutical Industries Business Overview
Table 112. Sun Pharmaceutical Industries Over-the-Counter Drugs Product and Services
Table 113. Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 114. Sun Pharmaceutical Industries Over-the-Counter Drugs SWOT Analysis
Table 115. Sun Pharmaceutical Industries Recent Development
Table 116. GlaxoSmithKline Company Details
Table 117. GlaxoSmithKline Business Overview
Table 118. GlaxoSmithKline Over-the-Counter Drugs Product and Services
Table 119. GlaxoSmithKline Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 120. GlaxoSmithKline Over-the-Counter Drugs SWOT Analysis
Table 121. GlaxoSmithKline Recent Development
Table 122. Boehringer Ingelheim Company Details
Table 123. Boehringer Ingelheim Business Overview
Table 124. Boehringer Ingelheim Over-the-Counter Drugs Product and Services
Table 125. Boehringer Ingelheim Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 126. Boehringer Ingelheim Over-the-Counter Drugs SWOT Analysis
Table 127. Boehringer Ingelheim Recent Development
Table 128. Bayer Company Details
Table 129. Bayer Business Overview
Table 130. Bayer Over-the-Counter Drugs Product and Services
Table 131. Bayer Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 132. Bayer Over-the-Counter Drugs SWOT Analysis
Table 133. Bayer Recent Development
Table 134. Alkem Laboratories Company Details
Table 135. Alkem Laboratories Business Overview
Table 136. Alkem Laboratories Over-the-Counter Drugs Product and Services
Table 137. Alkem Laboratories Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 138. Alkem Laboratories Recent Development
Table 139. Glenmark Pharmaceuticals Company Details
Table 140. Glenmark Pharmaceuticals Business Overview
Table 141. Glenmark Pharmaceuticals Over-the-Counter Drugs Product and Services
Table 142. Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 143. Glenmark Pharmaceuticals Recent Development
Table 144. Cipla Company Details
Table 145. Cipla Business Overview
Table 146. Cipla Over-the-Counter Drugs Product and Services
Table 147. Cipla Over-the-Counter Drugs Revenue in Over-the-Counter Drugs Business (2018-2024) & (US$ Million)
Table 148. Cipla Recent Development
Table 149. Over-the-Counter Drugs Market Trends
Table 150. Over-the-Counter Drugs Market Drivers
Table 151. Over-the-Counter Drugs Market Challenges
Table 152. Over-the-Counter Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Over-the-Counter Drugs Product Picture
Figure 2. Global Over-the-Counter Drugs Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Over-the-Counter Drugs Market Share by Type: 2022 VS 2034
Figure 4. Analgesics & Pain Relievers Features
Figure 5. Cough, Cold and Flu Products Features
Figure 6. Dermatological Products Features
Figure 7. Vitamin & Mineral Supplements Features
Figure 8. Gastrointestinal Products Features
Figure 9. Sleep Aids Features
Figure 10. Weight Loss Products Features
Figure 11. Smoking Cession Aids Features
Figure 12. Ophthalmic Products Features
Figure 13. Global Over-the-Counter Drugs Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 14. Global Over-the-Counter Drugs Market Share by Application: 2022 VS 2034
Figure 15. Hospital Pharmacies
Figure 16. Retail Pharmacies
Figure 17. Online Pharmacies
Figure 18. Over-the-Counter Drugs Report Years Considered
Figure 19. Global Over-the-Counter Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 20. Global Over-the-Counter Drugs Market Size 2018-2034 (US$ Million)
Figure 21. Global Over-the-Counter Drugs Market Size Market Share by Region: 2022 VS 2034
Figure 22. Global Over-the-Counter Drugs Revenue Market Share by Region in 2018 VS 2022
Figure 23. Global Over-the-Counter Drugs Revenue Market Share Forecast by Region (2024-2034)
Figure 24. Global Top 10 Over-the-Counter Drugs Countries Ranking by Market Size (US$ Million) in 2022
Figure 25. Global Over-the-Counter Drugs Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 26. Global Over-the-Counter Drugs Market Share by Players in 2022
Figure 27. Global Top Over-the-Counter Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over-the-Counter Drugs as of 2022)
Figure 28. The Top 10 and 5 Players Market Share by Over-the-Counter Drugs Revenue in 2022
Figure 29. North America Over-the-Counter Drugs Revenue Market Share by Company in 2022
Figure 30. North America Over-the-Counter Drugs Revenue Market Share by Type (2018-2034)
Figure 31. North America Over-the-Counter Drugs Revenue Market Share by Application (2018-2034)
Figure 32. North America Over-the-Counter Drugs Revenue Share by Country (2018-2034)
Figure 33. U.S. Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 34. Canada Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 35. Europe Over-the-Counter Drugs Revenue Market Share by Company in 2022
Figure 36. Europe Over-the-Counter Drugs Revenue Market Share by Type (2018-2034)
Figure 37. Europe Over-the-Counter Drugs Revenue Market Share by Application (2018-2034)
Figure 38. Europe Over-the-Counter Drugs Revenue Share by Country (2018-2034)
Figure 39. Germany Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 40. France Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 41. U.K. Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 42. Italy Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 43. Russia Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Company in 2022
Figure 45. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Type (2018-2034)
Figure 46. Asia Pacific Over-the-Counter Drugs Revenue Market Share by Application (2018-2034)
Figure 47. Asia Pacific Over-the-Counter Drugs Revenue Share by Region (2018-2034)
Figure 48. China Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 49. Japan Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 50. South Korea Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 51. India Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 52. Australia Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 53. Taiwan Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. Indonesia Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. Thailand Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Malaysia Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Philippines Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. Vietnam Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 59. Latin America Over-the-Counter Drugs Revenue Market Share by Company in 2022
Figure 60. Latin America Over-the-Counter Drugs Revenue Market Share by Type (2018-2034)
Figure 61. Latin America Over-the-Counter Drugs Revenue Market Share by Application (2018-2034)
Figure 62. Latin America Over-the-Counter Drugs Revenue Share by Country (2018-2034)
Figure 63. Mexico Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 64. Brazil Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 65. Argentina Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 66. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Company in 2022
Figure 67. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Type (2018-2034)
Figure 68. Middle East and Africa Over-the-Counter Drugs Revenue Market Share by Application (2018-2034)
Figure 69. Middle East and Africa Over-the-Counter Drugs Revenue Share by Country (2018-2034)
Figure 70. Turkey Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 71. Saudi Arabia Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 72. U.A.E Over-the-Counter Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. Johnson & Johnson Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 74. Merck Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 75. Novartis Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 76. Pfizer Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 77. Sanofi Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 78. Teva Pharmaceutical Industries Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 79. Sun Pharmaceutical Industries Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 80. GlaxoSmithKline Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 81. Boehringer Ingelheim Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 82. Bayer Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 83. Alkem Laboratories Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 84. Glenmark Pharmaceuticals Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 85. Cipla Revenue Growth Rate in Over-the-Counter Drugs Business (2018-2024)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed